PHARMACODYNAMICS AND CLINICAL USE OF GUANETHIDINE, BRETYLIUM AND METHYLDOPA

被引：36
作者：
KIRKENDALL, WM
WILSON, WR
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1962年 / 9卷 / 01期
关键词：
D O I：
10.1016/0002-9149(62)90104-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / &
相关论文
共 28 条
[1]  
ABBOUD FM, PERSONAL COMMUNICATI
[2]  
ABBOUD FM, 1961, CLIN RES, V9, P136
[3]  
BOURA ALA, 1959, LANCET, V2, P17
[4]   CLINICAL PHARMACOLOGY OF BRETYLIUM TOSYLATE - PRELIMINARY OBSERVATIONS [J].
CONWAY, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) :956-963
[5]  
DOLLERY CT, 1960, LANCET, V1, P296
[6]  
DOYLE AE, 1960, BRIT MJ, V5196, P422
[7]  
EMMELIN N, 1960, LANCET, V2, P263
[8]  
FINNERTY FA, CITED INDIRECTLY
[9]   SELECTIVE INHIBITION OF THE SYMPATHETIC NERVOUS SYSTEM IN MAN WITH BRETYLIUM TOSYLATE, A NEW ANTIHYPERTENSIVE AGENT [J].
FREIS, ED ;
SUGIURA, T ;
LIPTAK, D .
CIRCULATION, 1960, 22 (02) :191-197
[10]   CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE [J].
GILLESPIE, L .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) :1011-1020
123